CLINICAL ROLE -
What Drug Rates Are Reported in Price Transparency Data?
It is valuable for pharmacists to understand exactly how price transparency data are sourced, what information can be found, antitrust concerns, and implications for the pharmaceutical industry.
What Went Wrong: How Formularies, Contracts, and Rebates Created a Headwind for Biosimilars
Formularies have become one of the biggest barriers to realizing the cost-saving potential of biosimilars.
The Patient Prescription Pipeline: Enhancing Health Equity With Medically Integrated Pharmacies
Shifting from a vertical, isolated care model into a collaborative approach can improve the clinician and patient experience.
FTC Sues Major Pharmacy Benefit Managers Over Price of Insulin
Three of the largest pharmacy benefit managers ––Express Scripts, Optum, and Caremark––are listed in the suit.
Congress Requests Corrections to Testimony From Three Largest Pharmacy Benefit Manager Executives Following FTC Report
The request comes as increased scrutiny is levied toward pharmacy benefit managers for alleged unfair business practices.
